在实施全民筛查的国家中主要心脏缺陷的产前检出与结局
丹麦2018年1月至2022年12月全国队列研究纳入602例主要胎儿先天性心脏缺陷(mCHD),产前总检出率82.6%(497/602),单心室心脏检出率99.4%(159/160),完全性肺静脉异位引流检出率7.7%(1/13)。活产mCHD发生率为0.11%(1.1/1000活产),活产儿中92.0%(300/326)接受手术,随访8个月至5年死亡率为9.8%(32/326),其中50.0%为未手术的新生儿期死亡。
要点
- mCHD产前总检出率为82.6%(497/602),单心室心脏最高(99.4%,159/160),完全性肺静脉异位引流最低(7.7%,1/13)。
- 产前检出病例中52.5%(261/497)选择终止妊娠,占全部mCHD的43.4%(261/602)。
- 活产mCHD发生率0.11%(1.1/1000活产),活产儿手术率92.0%(300/326),多在生后1个月内手术。
核心结论
- 丹麦全国筛查项目下mCHD产前检出率提高、活产发生率下降,集中化诊疗使绝大多数患者接受手术且死亡率低;活产发生率下降需监测并进一步探索可能原因。
研究设计与样本
- 2018年1月至2022年12月丹麦5年全国性队列研究,从当地数据库检索645例mCHD妊娠及儿童,最终分析602例,排除未筛查、假阳性及分娩前移居者。
诊断标准与关键数值
- mCHD产前总检出率82.6%(497/602)。
- 单心室心脏产前检出率99.4%(159/160)。
- 完全性肺静脉异位引流产前检出率7.7%(1/13)。
临床应用与阅片要点
- 产前检出mCHD后43.4%(261/602)终止妊娠,产前检出病例中52.5%(261/497)选择终止妊娠。
- 活产mCHD发生率0.11%(1.1/1000活产),分娩中位孕周39+2周。
- 活产儿92.0%(300/326)接受手术,主要在生后1个月内;随访8个月至5年死亡率为9.8%(32/326),其中50.0%为未手术的新生儿期死亡。
局限性
- 原文结论指出活产mCHD发生率下降应予以监测并进一步探索可能原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the Danish prenatal screening program for major fetal congenital heart defects (mCHD), focusing on incidence, detection rates (DRs), pregnancy outcomes and postnatal mortality.
METHODS: This was a 5-year nationwide cohort study conducted from January 2018 to December 2022 in Denmark. We included pregnancies suspected of and/or with a confirmed mCHD and children with a confirmed mCHD, and excluded those who were not screened, false-positive cases and those who emigrated before delivery. The main outcome was the prenatal DR of mCHD. Secondary outcomes were rate of termination of pregnancy, liveborn incidence of mCHD, gestational age at delivery, neonatal surgery rate and postnatal mortality.
RESULTS: Data from a total of 645 pregnancies and children with mCHD were retrieved from local databases and 602 were included in the final analysis. The prenatal DR of mCHD was 82.6% (497/602), with one of the highest DRs observed for univentricular heart (99.4% (159/160)) and the lowest DR for total anomalous pulmonary venous return (7.7% (1/13)). Termination of pregnancy occurred in 43.4% (261/602) of cases, with 52.5% (261/497) of prenatally detected cases opting for termination. The liveborn incidence of mCHD was 0.11% (1.1 per 1000 births), and the median gestational age at delivery was 39 + 2 weeks. Surgery was performed in 92.0% (300/326) of liveborn children, primarily within the first month after birth. The postnatal follow-up time was between 8 months and 5 years, with a mortality rate of 9.8% (32/326), of which 50.0% occurred neonatally without surgery.
CONCLUSIONS: This study highlights increased prenatal DRs and a declining liveborn incidence of mCHD in Denmark, underscoring the efficacy of the national screening program and centralized care. Furthermore, the vast majority of patients were treated surgically, and the mortality rate was low. The declining liveborn incidence of mCHD should be monitored and potential causes explored further. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Vedel C, Steensberg J, Petersen OB, et al. Prenatal detection and outcome of major heart defects in a country with universal screening. Ultrasound Obstet Gynecol. 2025. PMID: 41118659. doi:10.1002/uog.70107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。